跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Loxeva - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Loxeva
Approved
STANDARD
Loxeva
Hizon Laboratories,Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d5c5ce247a814ebe
Company
Hizon Laboratories,Inc.
Type
Standard
Approval Details
Approval Id
d5c5ce247a814ebe
Drug Approval Philippines Name
Loxeva
Product Name
Loxeva
Registration Number
DRP-5178
Brand Name
Loxeva
Generic Name
Levofloxacin (as hemihydrate)
Dosage Form
Tablet
Dosage Strength
750 mg
Manufacturer
Hizon Laboratories,Inc.
Trader
The Cathay Drug Company, Inc.
Issuance Date
27 August 2020
Expiry Date
31 January 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d5c5ce247a814ebe
Type
Standard
Back to Philippines FDA Approvals